These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 34687672)
21. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice. Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A mBio; 2021 Apr; 12(2):. PubMed ID: 33879586 [TBL] [Abstract][Full Text] [Related]
22. Lung fibrosis: Post-COVID-19 complications and evidences. Hirawat R; Jain N; Aslam Saifi M; Rachamalla M; Godugu C Int Immunopharmacol; 2023 Mar; 116():109418. PubMed ID: 36736220 [TBL] [Abstract][Full Text] [Related]
23. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Venkataraman T; Frieman MB Antiviral Res; 2017 Jul; 143():142-150. PubMed ID: 28390872 [TBL] [Abstract][Full Text] [Related]
24. Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors. P KM; Sivashanmugam K; Kandasamy M; Subbiah R; Ravikumar V Life Sci; 2021 Feb; 266():118883. PubMed ID: 33316266 [TBL] [Abstract][Full Text] [Related]
25. Coronavirus disease 2019 in a patient with pulmonary fibrosis and emphysema: An autopsy report. Kudo R; Kawaguchi T; Kimura M; Rikitake Y; Iwao C; Rikitake M; Iwao K; Aizawa A; Kariya Y; Matsuda M; Miyauchi S; Takajo I; Sato Y; Asada Y; Miyazaki T; Umekita K Heliyon; 2023 Nov; 9(11):e22221. PubMed ID: 38045178 [TBL] [Abstract][Full Text] [Related]
26. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
27. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment. Rumende CM Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340 [TBL] [Abstract][Full Text] [Related]
29. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective. Lee C; Choi WJ Arch Pharm Res; 2021 Jan; 44(1):99-116. PubMed ID: 33398692 [TBL] [Abstract][Full Text] [Related]
30. Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β. Colarusso C; Terlizzi M; Maglio A; Molino A; Candia C; Vitale C; Hansbro PM; Vatrella A; Pinto A; Sorrentino R Front Immunol; 2022; 13():934264. PubMed ID: 35844548 [TBL] [Abstract][Full Text] [Related]
31. Post covid 19 pulmonary fibrosis. Is it real threat? Rai DK; Sharma P; Kumar R Indian J Tuberc; 2021 Jul; 68(3):330-333. PubMed ID: 34099197 [TBL] [Abstract][Full Text] [Related]
32. Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Richeldi L; Corsico AG Cells; 2021 May; 10(5):. PubMed ID: 34068958 [TBL] [Abstract][Full Text] [Related]
33. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. George PM; Wells AU; Jenkins RG Lancet Respir Med; 2020 Aug; 8(8):807-815. PubMed ID: 32422178 [TBL] [Abstract][Full Text] [Related]
34. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
35. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19. Zhang C; Wu Z; Li JW; Tan K; Yang W; Zhao H; Wang GQ J Med Virol; 2021 Mar; 93(3):1378-1386. PubMed ID: 33107641 [TBL] [Abstract][Full Text] [Related]
36. When things go wrong: exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases. Selman M; Pardo A Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 33542060 [TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188 [TBL] [Abstract][Full Text] [Related]
38. Pulmonary fibrosis in a dog as a sequela of infection with Severe Acute Respiratory Syndrome Coronavirus 2? A case report. Colitti B; Manassero L; Colombino E; Ferraris EI; Caccamo R; Bertolotti L; Bortolami A; Bonfante F; Papa V; Cenacchi G; Calabrese F; Bozzetta E; Varello K; Capucchio MT; Rosati S BMC Vet Res; 2022 Mar; 18(1):111. PubMed ID: 35317791 [TBL] [Abstract][Full Text] [Related]
39. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
40. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD). Gagiannis D; Steinestel J; Hackenbroch C; Schreiner B; Hannemann M; Bloch W; Umathum VG; Gebauer N; Rother C; Stahl M; Witte HM; Steinestel K Front Immunol; 2020; 11():587517. PubMed ID: 33123171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]